{
  "query": "follow herpes incidence zoster",
  "studies": {
    "protocolSection": [
      {
        "identificationModule": {
          "nctId": "NCT04188327",
          "briefTitle": "Stellate Ganglion Block in Herpes Zoster"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-05-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-02-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Pain", "Neuropathic"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 208,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "60 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01767467",
          "briefTitle": "Study to Assess the Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine in Adults Aged 18 Years and Older With Blood Cancers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-03-01"
          },
          "completionDateStruct": {
            "date": "2017-01-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Zoster"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 568,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04664530",
          "briefTitle": "The Study on the Esketamine in the Treatment of Postherpetic Neuralgia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-11-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Postherpetic Neuralgia", "Esketamine"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06643247",
          "briefTitle": "Electroacupuncture Regulation of Immune Cells in Herpes Zoster"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-11-11",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Herpes Zoster", "Electroacupuncture", "Immune"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 8,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "FEMALE",
          "minimumAge": "50 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07311148",
          "briefTitle": "A Immunogenicity and Safety Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 40 Years and Older"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-10-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Herpes Zoster (HZ)", "Shingles", "VZV", "Recombinant Zoster Vaccine"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 840,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05304351",
          "briefTitle": "Safety and Immunogenicity of CRV-101 Vaccine for the Prevention of Herpes Zoster in Adults Aged 50 Years and Older"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-02-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2032-03-06",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Herpes Zoster", "Shingles"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1516,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01165203",
          "briefTitle": "Study to Evaluate GSK Biologicals' Herpes Zoster Vaccine GSK1437173A in Human Immunodeficiency Virus (HIV)-Infected Subjects"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-09-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2013-05-14",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Zoster"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 123,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00929864",
          "briefTitle": "Abatacept Versus Adalimumab Head-to-Head"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-10"
          },
          "completionDateStruct": {
            "date": "2012-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Rheumatoid Arthritis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 869,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03563183",
          "briefTitle": "A Study to Assess Frailty of Subjects During ZOSTER-006 and ZOSTER-022"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-06-05",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-04-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Zoster"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 26976,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05775718",
          "briefTitle": "Shingrix In Recipients of Allogeneic Transplants"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-10-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2030-12-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Bone Marrow Transplant", "Stem Cell Transplant"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 55,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "79 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06654700",
          "briefTitle": "Phase III Clinical Trial of Lot-to-lot Consistency of Recombinant Herpes Zoster Vaccine (CHO Cell)."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-12-09",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-05-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Zoster"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04334577",
          "briefTitle": "Study on Efficacy of Attenuated Zoster Vaccine, Live"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-04-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-07-18",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Zoster"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25000,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05572567",
          "briefTitle": "Study to Evaluate Safety and Effects of Tofacitinib and Biologic Disease Modifying Antirheumatic Drugs in People Treated for Rheumatoid Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-10-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-10-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Arthritis, Rheumatoid"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1972,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02758223",
          "briefTitle": "Prophylactic Application of Donor-derived TCM After Allogeneic HSCT"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Leukemia, Myeloid, Acute", "Myelodysplastic Syndromes"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 16,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01762852",
          "briefTitle": "Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-04"
          },
          "completionDateStruct": {
            "date": "2014-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Glomerulonephritis, Membranous"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04091451",
          "briefTitle": "Safety and Immunogenicity Study of GlaxoSmithKline's Herpes Zoster Subunit Vaccine (HZ/su) When Given on a Two-dose Schedule to Adults at Least 50 Years of Age (YOA) With a Prior Episode of Herpes Zoster"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2019-09-17",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-02-15",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Zoster"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1430,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05750017",
          "briefTitle": "A Study to Evaluate Safety and Tolerability of a Recombinant Herpes Zoster Vaccine"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-03-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Herpes Zoster", "Vaccine-Preventable Diseases"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 66,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06088745",
          "briefTitle": "A Phase Ⅲ Clinical Study to Evaluate Protective Efficacy and Safety of a Recombinant Herpes Zoster Vaccine"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-09-28",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Vaccine-Preventable Diseases", "Herpes Zoster"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06942806",
          "briefTitle": "The Efficacy of High-frequency Short-time Spinal Cord Stimulation in the Treatment of Herpes Zoster-associated Neuralgia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-02-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-05-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Zoster Pain"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 74,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05470855",
          "briefTitle": "Protective Effect, Safety and Immunogenicity of Live Attenuated Varicella Vaccine in Anhui Province"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-07-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-02-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Varicella"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 45400,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "1 Year",
          "maximumAge": "12 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04072497",
          "briefTitle": "A Clinical Study of a Zoster Vaccine in Healthy Adults >= 40 Years"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-11-20",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-04-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Zoster"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 522,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04680884",
          "briefTitle": "Empirical Steroids and/or Antifungals in Immunocompromised Patients With Acute Respiratory Failure From Undetermined Etiology: a Multicenter Double-blind Randomized Controlled Trial"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-12-21",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2023-12-21",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Respiratory Failure", "Immunocompromised Patients"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 420,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "90 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02581436",
          "briefTitle": "Testing Immunosuppression Threshold in Renal Allografts To Extend eGFR"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-09"
          },
          "completionDateStruct": {
            "date": "2018-02-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Disorder Related to Renal Transplantation", "Renal Transplant Rejection", "Acute Graft Rejection"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 70,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "16 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06952465",
          "briefTitle": "A Study Comparing the Risk of Serious Infections and Malignancies With Deucravacitinib or Biologics in Japanese Patients With Psoriasis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-01-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-11-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Psoriasis"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 2000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06985589",
          "briefTitle": "Efficacy and Safety of Fire Needle Therapy Combined With Cortex Phellodendri Compound Fluid Wet Compress for Acute Herpes Zoster: a Randomized Controlled Trial."
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-08-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Herpes Zoster"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 32,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05636436",
          "briefTitle": "Safety and Immunogenicity of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 18 Years and Above"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Zoster"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 132,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03314103",
          "briefTitle": "Efficacy Trial of a Vaccine to Prevent Herpes Zoster in Adults Over 40 Years of Age"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2017-10-06",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-01-19",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Zoster"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30000,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06874842",
          "briefTitle": "Safety and Immunogenicity of the Recombinant Zoster Vaccine, LYB004 in Adults Aged 40 Years and Older"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-03-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-10",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Zoster (HZ)"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 92,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04189835",
          "briefTitle": "EVITA Study - Epstein-Barr Virus Infection moniToring in renAl Transplant Recipients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01-03",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12-31",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["EBV Infection", "EBV Viremia", "Epstein-Barr Virus Associated Lymphoproliferative Disorder", "Post-transplant Lymphoproliferative Disorder"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 509,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "2 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02092467",
          "briefTitle": "Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-03-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-07-22",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Arthritis, Rheumatoid"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 4372,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00534248",
          "briefTitle": "Study to Evaluate the Safety and Effectiveness of Zostavax™ in Subjects 50 - 59 Years of Age (V211-022)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2007-10"
          },
          "completionDateStruct": {
            "date": "2010-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Shingles"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 22439,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "59 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01521286",
          "briefTitle": "Study to Estimate the Burden of Herpes Zoster and Postherpetic Neuralgia in Spain"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-03"
          },
          "completionDateStruct": {
            "date": "2015-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Zoster"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 552,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05669014",
          "briefTitle": "A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-12-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-07-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Idiopathic Inflammatory Myositis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06447779",
          "briefTitle": "Efficacy, Safety and Immunogenicity Study of Recombinant Zoster Vaccine(CHO Cell) in Adults Aged 40 Years and Older"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-07-13",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-09",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Zoster"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02222857",
          "briefTitle": "Prophylactic Laser Photocoagulation and Vitrectomy for Acute Retinal Necrosis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2014-08"
          },
          "completionDateStruct": {
            "date": "2014-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Acute Retinal Necrosis", "Retinal Detachment", "Laser Photocoagulation", "Vitrectomy"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 23,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "20 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01165229",
          "briefTitle": "Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and Older"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-08-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2015-07-24",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Herpes Zoster", "Herpes Zoster Vaccine"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 14819,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT03809702",
          "briefTitle": "Efficacy of Pregabalin for the Treatment of Acute Herpetic Neuralgia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2018-07-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-12-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Zoster"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 82,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05460429",
          "briefTitle": "Immunogenicity, Safety and Protective Effect of Live Attenuated Varicella Vaccine and Study on Antibody Level and Etiology of Varicella Zoster Virus"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-07-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-05-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Varicella"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 37920,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "maximumAge": "59 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01229267",
          "briefTitle": "A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing Hematopoietic Cell Transplants (HCTs) (V212-001)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-11-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2015-12-23",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Zoster"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 1257,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07038707",
          "briefTitle": "Early Screening Markers of Herpes Zoster Neuralgia"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-07-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2026-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Postherpetic Neuralgia ( PHN )", "Lymphatic System Disorder"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 150,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01751165",
          "briefTitle": "Safety and Immunogenicity of Different Dosing Schedules of GlaxoSmithkline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine in Adults 50 Years of Age or Older"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-03-12"
          },
          "completionDateStruct": {
            "date": "2015-04-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Zoster"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 354,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02794285",
          "briefTitle": "Long Term Safety of Anifrolumab in Adult Subjects With Active Systemic Lupus Erythematosus"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-06-30",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2021-12-21",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Active Systemic Lupus Erythematosus"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 559,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04869982",
          "briefTitle": "Efficacy, Immunogenicity and Safety Study of GSKs Recombinant Zoster Vaccine Shingrix (GSK1437173A) in Chinese Adults Aged ≥50 Years"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2021-05-14",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-04-20",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Zoster"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 6138,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07170059",
          "briefTitle": "Observational Study on the Impact of Herpes Zoster Vaccine on the Incidence of Herpes Zoster and Survival in Lung Cancer Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-10-01",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2030-10-01",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Lung Cancer"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 500,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05225493",
          "briefTitle": "HIV Indicator Diseases in Hospital and Primary Care"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-01-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["HIV Infections", "Primary Health Care", "Acquired Immunodeficiency Syndrome", "Sexually Transmitted Diseases, Viral", "Herpes Zoster", "Dermatitis, Seborrheic", "Pneumonia", "Infectious Mononucleosis", "Psoriasis", "Candida Infection", "Lymphadenopathy", "Uterine Cervical Dysplasia", "Weight Loss", "Diarrhea Chronic", "Leukopenia", "Thrombocytopenia", "AIDS Defining Illness", "HIV Indicator Condition"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 1500,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05348382",
          "briefTitle": "The Efficacy and Safety of Intradermal Acupuncture for Acute Herpes Zoster"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-07-04",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Zoster"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 72,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "80 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07099157",
          "briefTitle": "Efficacy and Safety of Brivudine in the Treatment of Herpes Zoster"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-08-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2027-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Zoster"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 140,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07293065",
          "briefTitle": "Long-term Efficacy of Recombinant Zoster Vaccine (CHO Cell) Study"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12-19",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Zoster"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 12000,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07280741",
          "briefTitle": "Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases Under Immunomodulators"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12-03",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2028-07-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Autoimmune Rheumatic Diseases"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05596526",
          "briefTitle": "Immunogenicity of the Recombinant Zoster Vaccine in Multiple Sclerosis Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2022-12-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-12-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Shingles", "Zoster"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 100,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "60 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01772160",
          "briefTitle": "Study to Estimate the Burden of Herpes Zoster (HZ) and Post-herpetic Neuralgia (PHN) in Italy"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-02-26",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2016-10-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Herpes Zoster", "Herpes Zoster Vaccine"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 395,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07215754",
          "briefTitle": "Real World Evidence of Anifrolumab in Systemic Lupus Erythematosus: Investigator Initiated, Observational, Multicenter Study Evaluating Effectiveness and Safety of Anifrolumab in Active SLE Patients"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-25",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2031-05",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Systemic Lupus Erythematosus"
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 300,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT04133142",
          "briefTitle": "Regional Anesthesia to Relief Zoster Pain"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2020-05-15",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2022-11-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Zoster Without Complications"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 0,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "85 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05789615",
          "briefTitle": "Letermovir Prophylaxis for CMV Infection in Haplo-HSCT Recipients: Single-center Data in China"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-04-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-01-10",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["CMV Infection", "Hematopoietic Stem Cell Transplantation"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 200,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01254630",
          "briefTitle": "A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With Solid Tumor or Hematologic Malignancy (V212-011)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2011-06-24",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2017-04-11",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Zoster"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5305,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT07258771",
          "briefTitle": "Upadacitinib Combined With Corticosteroids vs Corticosteroid Monotherapy Induction for Inpatients and Outpatients With Acute Severe Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2030-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis Acute"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 110,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05856084",
          "briefTitle": "Immunogenicity and Safety of Recombinant Herpes Zoster Vaccine (CHO Cells) in Healthy Subjects Aged 30 Years and Above"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-07",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-03-31",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Zoster"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 924,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "30 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02902822",
          "briefTitle": "Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-10",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2019-05",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Erysipelas", "Impetigo", "Herpes Zoster", "Molluscum Contagiosum", "Warts", "Tinea", "Melanoma", "Actinic Keratosis", "Basal Cell Carcinoma", "Squamous Cell Carcinoma"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 461,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "99 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02668315",
          "briefTitle": "Expanded Cord Blood in Patients in Need of an Allogeneic Stem Cell Transplant"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2015-12-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2018-08",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Hematologic Malignancy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 25,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "3 Years",
          "maximumAge": "64 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06961721",
          "briefTitle": "A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase IV Clinical Trial to Evaluate the Immunogenicity and Safety of a Live Attenuated Herpes Zoster Vaccine in Adults Aged 40 Years and Older"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2025-05",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-12",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Prevention of Herpes Zoster"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 600,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05550194",
          "briefTitle": "VZV in the Enteric Nervous System: Pathogenesis and Consequences"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-03-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2026-08",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Achalasia"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 40,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT00226499",
          "briefTitle": "Evaluate Vaccine Against Chickenpox and a Combined Vaccine Against 4 Viral Childhood Diseases: Measles, Mumps, Rubella and Chickenpox"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2005-09-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2006-10-12",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Varicella", "Chickenpox Vaccines"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 5803,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "11 Months",
          "maximumAge": "22 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01077804",
          "briefTitle": "A Study to Evaluate Long-term Impact of VARIVAX Among Children and Adolescents (V210-036)(COMPLETED)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "1995-06-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2010-11-01",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Varicella", "Herpes Zoster"]
        },
        "designModule": {
          "studyType": "OBSERVATIONAL",
          "enrollmentInfo": {
            "count": 7585,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "12 Months",
          "maximumAge": "23 Months"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06476080",
          "briefTitle": "Ultrasound Guided Serratus Anterior Versus Erector Spinae Block in Pain Alleviation in Acute Herpes Zoster"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-07-05",
            "type": "ESTIMATED"
          },
          "completionDateStruct": {
            "date": "2025-04-15",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Acute Herpes Zoster Neuropathy"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 120,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "30 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05879419",
          "briefTitle": "Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-05-23",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2032-06-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": ["Rheumatoid Arthritis", "Spondylitis, Ankylosing", "Spondyloarthritis", "Systemic Lupus Erythematosus", "Sjogren's Syndrome", "Systemic Sclerosis", "Idiopathic Inflammatory Myopathies", "Vasculitis, Systemic", "Juvenile Idiopathic Arthritis", "Dermatomyositis, Juvenile", "Behçet Disease"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 2005,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01470612",
          "briefTitle": "Long-Term Study Of CP-690,550 In Subjects With Ulcerative Colitis"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2012-10-01",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2020-08-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Ulcerative Colitis"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 944,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT05769049",
          "briefTitle": "The Safety and Immunogenicity Study of the Recombinant Zoster Vaccine (CHO Cell)"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2023-02-09",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2023-12-06",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Zoster"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "40 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01536379",
          "briefTitle": "A Study of Belimumab in the Prevention of Kidney Transplant Rejection"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2013-09"
          },
          "completionDateStruct": {
            "date": "2016-02",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Transplantation, Organ"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 30,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": false,
          "sex": "ALL",
          "minimumAge": "18 Years",
          "maximumAge": "75 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT06335849",
          "briefTitle": "A Safety and Immunogenicity Trial of the Recombinant Zoster Vaccine （CHO Cell）, LYB004 in Adults Aged 50 to 70 Years"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2024-03-27",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2025-09-30",
            "type": "ESTIMATED"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Zoster"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 48,
            "type": "ESTIMATED"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "50 Years",
          "maximumAge": "70 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01165177",
          "briefTitle": "Study to Evaluate Efficacy, Safety and Immunogenicity of GSK Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 50 Years and Older"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2010-08-02",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2015-07-27",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": "Herpes Zoster"
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 16165,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT02723773",
          "briefTitle": "A Long-term Follow-up Study (ZOE-LTFU) of Two Studies 110390 (ZOSTER-006) and 113077 (ZOSTER-022) to Assess the Efficacy, Safety, and Immunogenicity Persistence of GSK Biologicals' Herpes Zoster Subunit (HZ/su) Vaccine and Assessment of 1 or 2 Additional Doses in Two Subgroups of Older Adults"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2016-04-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2024-01-30",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Herpes Zoster", "Herpes Zoster Vaccine"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 7539,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "50 Years"
        }
      },
      {
        "identificationModule": {
          "nctId": "NCT01049035",
          "briefTitle": "A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers"
        },
        "statusModule": {
          "startDateStruct": {
            "date": "2009-12-16",
            "type": "ACTUAL"
          },
          "completionDateStruct": {
            "date": "2012-02-13",
            "type": "ACTUAL"
          }
        },
        "conditionsModule": {
          "conditions": ["Meningitis", "Meningococcal Infection"]
        },
        "designModule": {
          "studyType": "INTERVENTIONAL",
          "enrollmentInfo": {
            "count": 580,
            "type": "ACTUAL"
          }
        },
        "eligibilityModule": {
          "healthyVolunteers": true,
          "sex": "ALL",
          "minimumAge": "42 Days",
          "maximumAge": "365 Days"
        }
      }
    ]
  }
}
